Edition:
United States

Sucampo Pharmaceuticals Inc (SCMP.OQ)

SCMP.OQ on NASDAQ Stock Exchange Global Market

15.45USD
2 Dec 2016
Change (% chg)

$-0.35 (-2.22%)
Prev Close
$15.80
Open
$15.80
Day's High
$16.00
Day's Low
$15.35
Volume
137,832
Avg. Vol
134,921
52-wk High
$18.75
52-wk Low
$9.61

SCMP.OQ

Chart for SCMP.OQ

About

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on research and development of drugs to treat gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It operates through development and commercialization of pharmaceutical products segment. Its operations are conducted through... (more)

Overall

Beta: 1.66
Market Cap(Mil.): $717.35
Shares Outstanding(Mil.): 45.84
Dividend: --
Yield (%): --

Financials

  SCMP.OQ Industry Sector
P/E (TTM): 52.60 42.21 29.87
EPS (TTM): 0.30 -- --
ROI: 5.01 -1.09 14.95
ROE: 10.17 -2.39 16.29

BRIEF-Sucampo Q3 adjusted EPS $0.28

* Sucampo pharmaceuticals inc - company raises 2016 guidance and provides preliminary 2017 guidance

Nov 09 2016

BRIEF-Sucampo reports Q2 GAAP loss per share $0.02

* Q2 earnings per share view $0.22 -- Thomson Reuters I/B/E/S

Aug 03 2016

BRIEF-Paul Edick joins Sucampo's board of directors

* Paul Edick joins Sucampo's board of directors Source text for Eikon: Further company coverage:

Jul 29 2016

BRIEF-Sucampo Pharmaceuticals updates on Cobiprostone Development Program

* Sucampo provides update on Cobiprostone Development Program Source text for Eikon: Further company coverage:

Jul 11 2016

Earnings vs. Estimates